<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230723058893N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-31</date_registration>
      <primary_sponsor>Mazandaran University of Medical Sciences</primary_sponsor>
      <public_title>Development and evaluation of the effectiveness of an AI-based educational–clinical platform as a "second reader" for Kellgren–Lawrence grading in knee radiography: a randomized controlled trial</public_title>
      <acronym></acronym>
      <scientific_title>Development and evaluation of the effectiveness of an AI-based educational–clinical platform as a "second reader" for Kellgren–Lawrence grading in knee radiography: a randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>280</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/92348</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Individual participants will be randomized in a 1:1 allocation ratio to either the control group or the intervention group. A variable block randomization method will be used to generate the allocation sequence. Where feasible, randomization will be stratified by educational specialty and baseline skill level to maintain balance between the study groups. Randomization will be performed after completion of the pre-test. Allocation concealment will be maintained until completion of the pre-test, after which the appropriate software access will be assigned according to the participant’s allocated group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee Osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Standard digital knee radiographs evaluated using the deep learning (AI) algorithm to grade knee osteoarthritis according to the Kellgren-Lawrence (KL) classification criteria. Intervention 2: Control group: Standard training without AI output.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Study protocol, statistical analysis plan, and informed consent form: These documents contain the methodology, statistical analysis details, and participant consent procedures for evaluating the AI model's accuracy in knee osteoarthritis grading

When:
Starting 6 months after the publication of the study results for a period of up to 5 years

To whom:
Available to academic researchers and clinicians affiliated with universities or research centers upon reasonable request

Conditions:
For scientific research, systematic reviews, and meta-analyses related to artificial intelligence applications in knee osteoarthritis grading, subject to approval of the study proposal by the primary investigator

Where to obtain:
Obtainable by submitting a formal request via email to the corresponding author / principal investigator

How to obtain:
Applicants must submit a formal request and research proposal to the principal investigator via email. The proposal will be reviewed within 2 to 4 weeks, and upon approval, the documents will be provided

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elaheh Sadat Hosseini.</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 3, Ayatollah Salehi Alley, Mir Mashhad Neighborhood, Behind Ibn Ashub Library, Islamic Republic Street, Sari, Mazandaran Province</address>
        <city>sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816646796</zip>
        <telephone>+98 915 264 8141</telephone>
        <email>sadathosseini767676@gmail.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Elaheh Sadat Hosseini.</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 3, Ayatollah Salehi Alley, Mir Mashhad Neighborhood, Behind Ibn Ashub Library, Islamic Republic Street, Sari, Mazandaran Province</address>
        <city>sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4816646796</zip>
        <telephone>+98 915 264 8141</telephone>
        <email>sadathosseini767676@gmail.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Provision of written informed consent
Stable access to the internet and a computer for using the platform
No significant prior experience with Kellgren–Lawrence grading or AI-based diagnostic support systems, based on a self-reported screening checklist
Ability to complete the pre-test and post-test within the specified timeframe</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having significant prior experience in KL grading
Having significant prior experience working with AI-based computer-aided diagnostic systems.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>Diagnosis</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Standard digital knee radiographs evaluated using the deep learning (AI) algorithm to grade knee osteoarthritis according to the Kellgren-Lawrence (KL) classification criteria</i_keyword>
      <i_keyword>Control group: Standard training without AI output.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Diagnostic accuracy of deep learning algorithm in grading knee osteoarthritis based on Kellgren-Lawrence (KL) criteria. Timepoint: Baseline (immediately upon evaluation of knee radiographs by the AI model and human readers). Method of measurement: Evaluated by deep learning model and expert radiologists using the Kellgren-Lawrence grading system on standard weight-bearing anteroposterior knee radiographs.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Diagnostic sensitivity, specificity, and processing time of the deep learning algorithm compared to expert radiologists in detecting knee osteoarthritis. Timepoint: Baseline (immediately upon evaluation of knee radiographs by the AI model and human readers). Method of measurement: Statistical analysis using Cohen's kappa coefficient to assess inter-observer agreement, and receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance parameters.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mazandaran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-16</approval_date>
        <contact_name>mam (RA) Teaching and Therapeutic Hospital of Sari - Mazandaran University of Medical Sciences (Res</contact_name>
        <contact_address>No. 3, Ayatollah Salehi Alley, Mir Mashhad Neighborhood, Behind Ibn Ashub Library, Islamic Republic Street, Sari, Mazandaran Province sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
